Ethnicity in neuro-oncology research: How are we doing and how can we do better?
Open Access
- 24 September 2024
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 170 (2) , 223-233
Abstract
Purpose: This study systematically reviews and meta-analyses the extent of ethnic minority representation in neuro-oncology Phase III and IV clinical trials, explores the effect of ethnicity on outcomes, and identifies predictors for the inclusion of ethnicity data in publications. Methods: Adhering to PRISMA guidelines, we conducted a comprehensive literature search across multiple databases, on Phase III and IV trials in neuro-oncology that reported on adult and/or paediatric subjects. Through meta-analysis, we synthesized information on overall survival, event-free survival, and the incidence of adverse outcomes across ethnicities. Results: From 448 identified articles, a fraction reported ethnicity data, with an even smaller number providing outcome data stratified by ethnicity. Most study participants were identified as White, underscoring a significant underrepresentation of minorities. Our meta-analysis did not reveal significant outcome differences by ethnicity, which may be attributed to the limited and inadequate reporting of data. Predictors for including ethnicity data were identified, including trials in North America(OR2.39, 95%CI 1.18–5.12, p < 0.02),trials of drugs or biologic agents(OR 5.28, 95%CI 1.43–3.42, p < 0.05),and trials funded by charities(OR 2.28, 95% CI 1.04–5.27, p < 0.05) or pharmaceutical companies(OR 3.98, 95% CI 1.60–10.0, p < 0.005). Conclusion: The underrepresentation of minorities in neuro-oncology clinical trials and the inadequately characterized impact of ethnicity on treatment outcomes highlight a critical need for more inclusive recruitment strategies and improved reporting standards. Change is necessary to ensure trials reflect the diversity of the patient population, which is essential for developing tailored strategies and improving outcomes. Future research should prioritize understanding the role of ethnicity in neuro-oncology to facilitate personalized treatment approaches.Keywords
This publication has 44 references indexed in Scilit:
- Racial and socioeconomic disparities in glioblastoma outcomes: A single‐center, retrospective cohort studyCancer, 2023
- Prognostication in brain tumors2022
- Racial/ethnic and sex differences in young adult malignant brain tumor incidence by histologic typeCancer Epidemiology, 2021
- Asians and Asian Subgroups are Underrepresented in Medical Research Studies Published in High-Impact Generalist JournalsJournal of Immigrant and Minority Health, 2021
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014JAMA Oncology, 2018
- Arab American Health in a Racially Charged U.S.American Journal of Preventive Medicine, 2017
- Twenty years post‐NIH Revitalization Act: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrualCancer, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- A systematic review of the factors influencing African Americans' participation in cancer clinical trialsContemporary Clinical Trials, 2013
- Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 — The perspective of NIH clinical trialistsControlled Clinical Trials, 1995